 nonrandom infants acute megakaryoblastic leukemia Pediatric Oncology Group Study nonrandom occurrence frequency acute myeloid leukemia AML close association French-American-British subtype AML infants year chromosomal abnormality children adolescents AML infants AML cases overall cases infants Infants AML subtype prominent abdominal masses infants treated infants complete remission therapy AML infant hemorrhage day infants remission alive disease free months infants bone marrow months start therapy AML infants extensive infiltration abdominal organs leukemic cells poor prognosis intensive AML-directed treatment Identification nonrandom translocation infants acute megakaryoblastic leukemia AMkL additional diagnostic marker disease pathogenesis AMkL infants